HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Month: September 2024
Five potential solutions to the US kidney shortage
Kidneys are currently the most needed organ in the country, and an ongoing crisis has left tens of thousands in...
Research Impact: School of Medicine researcher reduces disparities for liver cancer patients: IU News
Research Impact is a series that pulls back the curtain of IU Research, showcasing the faculty creating, innovating and advancing...
Transplantation reduces healthcare costs, says Swisstransplant
Around two-thirds of patients on a waiting list for organ donation need a new kidney, says Swisstransplant. Keystone / Martial...
Another Possible Treatment Option for Intermediate-Stage Liver Cancer
Progression-free survival (PFS) in intermediate-stage hepatocellular carcinoma (HCC) improved by almost 5 months when a targeted agent and immunotherapy were...
Popular medicine to treat menopause-related hot flashes can lead to serious liver injury, FDA warns – Healthcare News
The U.S. Food and Drug Administration (FDA) on Friday issued a warning that Veozah (fezolinetant), a medicine used to treat...
